Results 91 to 100 of about 4,412 (151)

The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions

The FEBS Journal, Volume 292, Issue 6, Page 1480-1499, March 2025.
Vaccination plays a crucial role in mediating protection against infectious diseases, but immune responses to vaccination are highly variable and frequently sub‐optimal in vulnerable populations. Here, we review the latest preclinical and clinical evidence demonstrating that the gut microbiota plays a significant role in regulating immune responses to ...
Charné Rossouw, Feargal J. Ryan, David J. Lynn   +2 more
wiley   +1 more source

Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.

PLoS ONE, 2022
The kinetics and magnitude of antibody responses to different proteins of the SARS-CoV-2 virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we investigated antibody responses to different SARS-CoV-2 proteins at 2 weeks, 3
Chandima Jeewandara, Inoka Sepali Aberathna, Shashika Dayarathna, Thashmi Nimasha, Thushali Ranasinghe, Jeewantha Jayamali, Achala Kamaladasa, Maneshka Karunanada, Lahiru Perera, Graham S Ogg, Gathsaurie Neelika Malavige   +10 more
doaj   +1 more source

Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points

Journal of Medical Virology, Volume 97, Issue 1, January 2025.
ABSTRACT As the COVID‐19 pandemic continues, increasingly complex vaccination and infection histories have made it urgent to investigate the antibody dynamics in populations with hybrid immunity. This study aimed to explore the multi‐time‐point dynamics of SARS‐CoV‐2 IgG antibody levels in a community‐based population in Jiangsu Province, China ...
Shihan Zhang, Xiaoxiao Kong, Qian Zhen, Ye Wei, Chao Shi, Songning Ding, Liling Chen, Chen Dong, Hua Tian, Chuchu Li, Lu Zhou, Yazhen Zhang, Fengcai Zhu, Jianli Hu, Changjun Bao, Hui Jin, Ke Xu, Liguo Zhu   +17 more
wiley   +1 more source

Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh. [PDF]

BACKGROUND: Due to the ongoing COVID-19 pandemic, various host countries such as Singapore, imposed entry requirements for migrant workers including pre-departure COVID-19 seroconversion proof. To combat COVID-19 worldwide, several vaccines have acquired
Amin, N, Hasan, R, Hossain, MI, Rahman, M, Rahman, MZ, Raqib, R, Sarker, P, Svezia, CK   +7 more
core   +1 more source

Reporte Breve N° 04-2021. Evaluación de la eficacia y seguridad de la vacunación de refuerzo con la vacuna BNT162b2 (Comirnaty), en pacientes que recibieron el esquema de vacunación completa con la vacuna BBIBP-CorV (Sinopharm) [PDF]

, 2021
A la fecha 28 de junio del 2021, no se dispone de evidencia publicada con respecto a la eficacia y seguridad de la aplicación de una o dos dosis de la vacuna BNT162b2 en pacientes que han recibido el esquema de vacunación completo de la vacuna BBIBP ...
Seguro Social de Salud (EsSalud). Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI)
core  

Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice

Microbial Biotechnology, Volume 18, Issue 1, January 2025.
Mucosal vaccines using food‐grade bacteria, such as lactic acid bacteria, are promising strategies for developing effective vaccines against SARS‐CoV‐2. In this study, we designed a non‐GMO surface‐displayed SARS‐CoV‐2 spike S1 epitope on Limosilactobacillus fermentum‐derived BLP.
Robie Vasquez, Ji Hoon Song, Remilyn M. Mendoza, In‐Chan Hwang, Bernadette B. Bagon, Lars Engstrand, Valerie Diane Valeriano, Dae‐Kyung Kang   +7 more
wiley   +1 more source

The Effectiveness and Influence of COVID‐19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta‐Analysis

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
Background: The COVID‐19 pandemic has disproportionately affected pregnant individuals, increasing risks of severe illness and adverse outcomes. While vaccination is a key mitigation strategy, initial exclusion from clinical trials led to limited safety data. Despite evidence of vaccine effectiveness, hesitancy persists in this population.
Zi-Jin Lei, Min-Xi Bai, Min-Jue Li, Peng Jin, Yu-Bin Ding, Timotius Ivan Hariyanto   +5 more
wiley   +1 more source

Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review [PDF]

The emergence of the SARS-CoV-2 virus worldwide led to the call for the development of effective and safe vaccines to contain the spread and effects of COVID-19.
Azeem M., Cancemi P., De Caro V., Di Prima G., Marino S., Mukhtar F., Peri E.   +6 more
core   +1 more source

Reporte Breve N° 06-2021. Eficacia y seguridad de la vacuna inactivada BBIBP-CORV (Sinopharm) [PDF]

, 2021
La vacuna inactivada BBIBP-CorV puede considerarse para la prevención de casos sintomáticos confirmados de la COVID-19, sobre todo en la población entre 18 y 59 años de edad sin comorbilidades.
Seguro Social de Salud (EsSalud). Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI)
core  

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

Journal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi, Hossein Kargar Jahromi, Nazanin Shafiei Jahromi, Mina Molayem, Poorani Gurumallesh   +4 more
wiley   +1 more source